에서 실시간으로 운영 중이에요! 자세히 알아보기

Innospec

IOSP

시가총액 US$23.8억

96.81 USD

+0.21

0.22%

장 마감 시점 업데이트됨 10월 16일 PM 4:00 EDT

프리마켓

시간외 거래

96.81

0.00

0%

1일

0.22%

5일

1.16%

1개월

4.18%

3개월

13.28%

6개월

28.93%

연초 이후

26.91%

1년

30.49%

5년

11.38%

10년

57.85%

소개: Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.

직원 수: 2,450

소재 특수화학물질

뉴스

긍정적

중립

부정적

투자 심리 3개월

긍정적 53.8%

중립 38.5%

부정적 7.7%

Innospec Schedules Third Quarter 2026 Earnings Release and Conference Call

ENGLEWOOD, Colo., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release third quarter 2026 earnings results on Tuesday, November 3, 2026 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, November 4, 2026, at 9:00 a.m. ET.

Innospec Schedules Third Quarter 2026 Earnings Release and Conference Call

Zacks Investment Research

Innospec (IOSP) Up 2% Since Last Earnings Report: Can It Continue?

Innospec (IOSP) reported earnings 30 days ago. What's next for the stock?

Innospec (IOSP) Up 2% Since Last Earnings Report: Can It Continue?

Zacks Investment Research

4 Diversified Chemical Stocks to Gain Amid Stable End-market Demand

The Zacks Chemicals Diversified is expected to benefit from healthy demand across major end-use markets and the end of destocking activities. APD, DD, AVNT and IOSP are set to gain from strategic actions and demand recovery.

4 Diversified Chemical Stocks to Gain Amid Stable End-market Demand

Innospec: Topline Is Growing As Expected

With the oilfield segment leading topline growth, even more growth should be expected as the adoption of DRA expands and the firm re-enters the Mexico market. In Q2 of 2026, revenue grew 12%, beating estimates by $34.17 million. The firm is now in a better financial position to command a higher sales multiple. The Performance chemical segment still experiences volume declines, raising concerns about the firm over investing by adding 10% capacity in a weak market.

Innospec: Topline Is Growing As Expected

Zacks Investment Research

IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth

Innospec's Q2 earnings beat estimates as all three businesses delivered revenue growth, while a debt-free balance sheet supports further investment.

IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth

Zacks Investment Research

Is Innospec (IOSP) Stock Outpacing Its Basic Materials Peers This Year?

Here is how Innospec (IOSP) and Ingevity (NGVT) have performed compared to their sector so far this year.

Is Innospec (IOSP) Stock Outpacing Its Basic Materials Peers This Year?

Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript

Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript

Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript

Innospec Q2 Earnings Call Highlights

Innospec NASDAQ: IOSP reported higher second-quarter revenue and net income as all three operating segments posted double-digit sales growth and operating-income gains, while the company continued repair and optimization work at its North Carolina Performance Chemicals facilities.

Innospec Q2 Earnings Call Highlights

Zacks Investment Research

Innospec (IOSP) Tops Q2 Earnings and Revenue Estimates

Innospec (IOSP) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.26 per share a year ago.

Innospec (IOSP) Tops Q2 Earnings and Revenue Estimates

Innospec Reports Second Quarter 2026 Financial Results

Strong contributions from all businesses with revenues up 12 percent and operating income up 16 percent

Innospec Reports Second Quarter 2026 Financial Results

뉴스 순위 보기

Lightweight Charts™를 사용해 가격 차트를 구현했어요.